Constructive Bio Strengthens Management Team and Board of Directors with Key Appointments to Accelerate Synthetic Genomics to Innovate Biologic Therapies Industry veteran Dr Paul Wallace appointed as ...

Project backed by £9.1m funding from ARIA, the Advanced Research + Invention Agency, to develop synthetic chloroplast genomes Project is led by the Max-Planck Institute of Molecular Plant Physiology ...

Industry veteran Dr Paul Wallace appointed as Chief Business Officer bringing 25 years of international business development experience commercialising innovative platforms and therapeutics Boston, MA ...

Camena Bioscience (Camena), an innovator in enzymatic DNA synthesis, and Constructive Bio (Constructive), a pioneer in whole genome writing, today announced they have joined a collaborative project ...